EBioMedicine

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Research examines key factors related to COVID-19 variant dynamics

A team of researchers at Los Alamos National Laboratory recently published the most comprehensive study of global COVID-19 variant transitions, which showed significant diversity in variant spread around the globe related ...

Oncology & Cancer

AI could help doctors diagnose lung cancer

Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, ...

Cardiology

Estrogen possible risk factor in disturbed heart rhythm

The sex hormone estrogen has a negative impact on heartbeat regulation, according to an experimental study from Linköping University, Sweden, published in Science Advances. Estrogen impact seems to interact with hereditary ...

page 1 from 25